Mar 21, 2014Frost & Sullivan Presents Sensus Healthcare with Prestigious New Product Innovation Leadership Award for Non-Melanoma Skin Cancer TherapyThe SRT-100™ and SRT-100 Vision™ are used to treat a host of dermatological and oncological conditions with low-energy radiation therapy
Frost & Sullivan has recognized Sensus Healthcare with the 2014 North American award for New Product Innovation Leadership. Each year, Frost & Sullivan presents this award to the company that has...
Sep 10, 2013
Sensus Healthcare is proud to announce their newest introduction for non-melanoma skin cancer treatment at the 55th annual American Society of Therapeutic Radiation Oncology in Atlanta, GA. on...
Aug 28, 2013
Sensus Healthcare is pleased to announce Dr. Mark Nestor as Clinical Director. Dr. Nestor joins a distinguished panel of Medical Advisory Board Members. He will lead the Company's efforts in the...
Jul 27, 2013
The Food and Drug Administration (FDA) has recently gave Sensus Healthcare the clearance to use its revolutionary product, the SRT-100, the green signal t treat hypertrophic scars and keloid...
Jul 15, 2013
Sensus Healthcare is pleased to announce Dr. Clay Cockerell as Medical Director. Dr. Cockerell will lead the distinguished members of the Medical Advisory Board as the Company continues to provide...